|
|
Efficacy comparison of four adjustment cycles after hemostasis in adolescent abnormal uterine bleeding-ovulatory disorders |
LIU Wei JIANG Zhuang-liang DU Xiao-han |
Department of Reproductive Health,Jiangxi Maternal and Child Health Hospital,Jiangxi Province,Nanchang 330006,China |
|
|
Abstract Objective To compare the efficacy of four adjustment cycle programs after hemostasis in adolescent abnormal uterine bleeding-ovulatory disorders(AUB-O).Methods A total of 100 adolescent AUB-O patients who were admitted to the Outpatient and Inpatient Department of Jiangxi Maternity and Child Health Hospital from June 2016 to June 2018 were selected.They were divided into four groups by a random number table method,with 25 cases in each group.Progesterone regimen was used in group A;artificial cycle at a low-dose estrogen regimen was used in group B;artificial cycle in a routine estrogen regimen was used in group C;contraceptive regimen of Ethinyl Estradiol and Cyproterone Tablets was adopted in group D.All of these interventions were treated continuously for three cycles and followed up for six months.The clinical efficacy of the four groups after treatment,the incidence of adverse reactions during treatment,the biphasic rate of basal body temperature(BBT)and the recurrence rate at the end of follow-up were compared.Results After three cycles of treatment,the total effective rate of treatment in group D was higher than that of group A,B,and C,with statistical significance(P<0.05).There was no significant difference in total effective rate of treatment among group A,B,and C(P>0.05).There was no significant difference in the occurrence of adverse reactions among the four groups(P>0.05).After six months of follow-up,the biphasic rate of BBT in group D was higher than that of group A,B,and C,with statistical significance(P<0.05).There was no significant difference in the biphasic rate of BBT in group A,B,and C(P>0.05).The recurrence rate of group D was lower than that of group A,B,and C,with statistical significance(P<0.05).On regard of the recurrence rate,there was no significant difference among group A,B,and C(P>0.05).Conclusion Oral administration of Ethinyl Estradiol and Cyproterone Tablets can increase the biphasic rate of BBT in adolescent AUB-O patients,reduce the recurrence rate,without significant increase of the incidence of adverse reactions.The safety and effectiveness of the treatment are good.
|
|
|
|
|
[1] |
中华医学会妇产科学分会妇科内分泌学组.异常子宫出血诊断与治疗指南[J].中华妇产科杂志,2014,49(11):801-806.
|
[2] |
中华医学会妇产科学分会妇科内分泌学组.排卵障碍性异常子宫出血诊治指南[J].中华妇产科杂志,2018,53(12):801-807.
|
[3] |
谢幸,苟文丽.妇产科学[M].9 版.北京:人民卫生出版社,2019:344-368.
|
[4] |
王蔚文.临床疾病诊断与疗效判断标准[M].北京:科学技术文献出版社,2010:937.
|
[5] |
刘瑞敏.雌孕激素复合避孕药治疗青春期功能失调性子宫出血的临床效果分析[J].河南医学研究,2016,25(12):2267-2268.
|
[6] |
吉朝花.妈富隆联合小剂量米非司酮治疗围绝经期功能失调性子宫出血效果及安全性分析[J].基层医学论坛,2019,23(20):2839-2840.
|
[7] |
时妍嫣.去氧孕烯炔雌醇片在围绝经期异常子宫出血治疗中的应用效果探究[J].药品评价,2019,16(10):32-34.
|
[8] |
黄颖,高波,李玲.两种方法治疗青春期功能失调性子宫出血98 例临床疗效分析[J].海军医学杂志,2016,73(2):170-172.
|
[9] |
程军,潘泉利.益母草方剂配合小剂量激素治疗中老年功能性子宫出血[J].吉林中医药,2017,37(12):1226-1229.
|
[10] |
刘燕.致康胶囊联合戊酸雌二醇治疗青春期功能失调性子宫出血的疗效观察[J].现代药物与临床,2019,34(7):2087-2092.
|
[11] |
高新华,赵海燕.雌孕激素复合口服避孕药治疗功能失调性子宫出血49 例的临床效果[J].临床医学研究与实践,2017,2(28):75-76.
|
[12] |
李艳.第三代口服避孕药与天然孕激素治疗青春期功能失调性子宫出血临床疗效探讨[J].中国药物与临床,2015,15(1):98-100.
|
[13] |
熊烨.达英-35 治疗围绝经期功血的临床疗效[J].药品评价,2019,16(23):79-80.
|
[14] |
陈艳琴,黄凌云,顾燕芳,等.达英-35、炔诺酮和黄体酮治疗围绝经期异常子宫出血疗效及安全性分析[J].北华大学学报(自然科学版),2019,20(4):502-505.
|
[15] |
黄颖,高波,李玲,等.两种方法治疗青春期功能失调性子宫出血98 例临床疗效分析[J].海军医学杂志,2016,37(2):170-172.
|
|
|
|